- Home
- applications
- usa california
- health application for monitoring
Show results for
Refine by
Health Application For Monitoring Product Applications In Usa California
9 applications found
This application note describes the utility of SRSLY in performing targeted sequence analysis of SAR-CoV-2 RNA-Seq libraries were generated with SRSLY within 3 hours. Subsequent enrichment of viral sequences can be performed with a user-preferred hybridization-based panel. ...
ByClaret Bioscience based in Santa Cruz, CALIFORNIA (USA)
Ideal for high throughput surgery to avoid pre and post complications. ...
ByMediPines based in Yorba Linda, CALIFORNIA (USA)
The most comprehensive view of the genome to realize the future of precision ...
ByRoswell Biotechnologies Inc based in San Diego, CALIFORNIA (USA)
Cell-free DNA (cfDNA), found circulating in blood plasma, contains a wealth of clinically relevant biological information which can be recovered by minimally-invasive procedures. Next Generation Sequencing (NGS) data obtained from cfDNA, can be used to monitor prenatal health, organ transplant reception or rejection, cancer and other ...
ByClaret Bioscience based in Santa Cruz, CALIFORNIA (USA)
A wide range of products and services to acoustically test imaging and doppler transducers to ensure safety and ...
ByOnda Corporation based in Sunnyvale, CALIFORNIA (USA)
In your environment - in your home - at the clinic. Current Testing is Failing the Modern World. Low-plex: Many types of tests are required to diagnose disease today. Centralized: Centralized testing is slow and complex and remains a barrier to connected health. Limited Access: Lack of access propagates disease in the community: Cost and testing are fundamental ...
ByRoswell Biotechnologies Inc based in San Diego, CALIFORNIA (USA)
(POC) rapid evaluation for assessing patient risk and care ...
ByMediPines based in Yorba Linda, CALIFORNIA (USA)
SRSLY NGS library preparation with twist exome panel enrichment for ctDNA SNP profiling. Cell-free DNA (cfDNA), found circulating in blood, originates predominantly from dying cells. In healthy individuals the vast majority of cfDNA derives from hematopoietic myeloid and lymph cells undergoing apoptosis. However, in individuals with cancer, a variable fraction of the cfDNA derives from tumor cells undergoing apoptosis and/or necrosis. This tumor derived fraction of cfDNA is known as circulating tumor DNA (ctDNA). ...
ByClaret Bioscience based in Santa Cruz, CALIFORNIA (USA)
RPM allows you to gather health data from your patients at home, improving outcomes and bringing new revenue into your ...
ByAthelas Incorporated based in Mountain View, CALIFORNIA (USA)